How effective is Requip for Plmd (Restless leg syndrome) ?


Summary

362 Requip users have rated its effectiveness for Plmd.

Overall ratings: 3.6/5
Long term ratings: 3.8/5

This is a reivew of how effective Requip (ropinirole hydrochloride) is for Plmd and for what kind of people. The study is created by eHealthMe and is updated continuously.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 07, 2017

362 people are studied for taking Requip in Plmd


Overall effectiveness (number of people)

Does Requip work for your Plmd (overall)?

Long term effectiveness (number of people)

Does Requip work for your Plmd (long term)?

Requip effectiveness for Plmd (number of people)

Overall:
  • not at all: 5
  • somewhat: 56
  • moderate: 97
  • high: 130
  • very high: 74
Long Term:
  • not at all: 1
  • somewhat: 16
  • moderate: 64
  • high: 86
  • very high: 56

Gender of people who take Requip for Plmd *

  • female: 79.28 %
  • male: 20.72 %

Age of people who take Requip for Plmd *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.83 %
  • 20-29: 3.87 %
  • 30-39: 16.85 %
  • 40-49: 20.99 %
  • 50-59: 30.11 %
  • 60+: 27.35 %

Who finds Requip more effective for Plmd?


Gender of people who take Requip for Plmd *

  • female: 79.9 %
  • male: 20.1 %

Age of people who take Requip for Plmd *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.49 %
  • 20-29: 1.96 %
  • 30-39: 16.18 %
  • 40-49: 21.57 %
  • 50-59: 27.94 %
  • 60+: 31.86 %

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Requip

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. (latest outcomes from Requip 16,398 users)

Plmd

Plmd has been reported by people with restless leg syndrome, depression, osteoporosis, multiple sclerosis, pain (latest reports from 26,749 Plmd patients).

Related studies: